These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11043149)

  • 21. Loss of intellectual function in children with phenylketonuria after relaxation of dietary phenylalanine restriction.
    Seashore MR; Friedman E; Novelly RA; Bapat V
    Pediatrics; 1985 Feb; 75(2):226-32. PubMed ID: 3969322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intellectual development after relaxing the diet at the age of 5 years in typical phenylketonuria].
    Abadie V; Rey F; Plainguet F; Rey J
    Arch Fr Pediatr; 1992 Nov; 49(9):773-8. PubMed ID: 1300964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intellectual development of phenylketonuria children treated early--a longitudinal study. 10 years' concomitant psychological study in The Netherlands].
    Slijper FM; Huisman J; Hendrikx MM; Kalverboer AF; van der Schot L
    Monatsschr Kinderheilkd; 1989 Oct; 137(10):662-5. PubMed ID: 2586531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
    Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
    Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Summary of findings from the United States Collaborative Study of children treated for phenylketonuria.
    Azen C; Koch R; Friedman E; Wenz E; Fishler K
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S29-32. PubMed ID: 8828605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Austrian report on longitudinal outcome in phenylketonuria.
    Scheibenreiter S; Tiefenthaler M; Hinteregger V; Strobl W; Mühl A; Ewald A; Schadler M
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S45-9. PubMed ID: 8828608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variability in phenylalanine control predicts IQ and executive abilities in children with phenylketonuria.
    Hood A; Grange DK; Christ SE; Steiner R; White DA
    Mol Genet Metab; 2014 Apr; 111(4):445-51. PubMed ID: 24568837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early breastfeeding is linked to higher intelligence quotient scores in dietary treated phenylketonuric children.
    Riva E; Agostoni C; Biasucci G; Trojan S; Luotti D; Fiori L; Giovannini M
    Acta Paediatr; 1996 Jan; 85(1):56-8. PubMed ID: 8834980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of stopping low-phenylalanine diet on intellectual progress of children with phenylketonuria.
    Smith I; Lobascher ME; Stevenson JE; Wolff OH; Schmidt H; Grubel-Kaiser S; Bickel H
    Br Med J; 1978 Sep; 2(6139):723-6. PubMed ID: 698696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychoeducational findings among children treated for phenylketonuria.
    Fishler K; Azen CG; Henderson R; Friedman EG; Koch R
    Am J Ment Defic; 1987 Jul; 92(1):65-73. PubMed ID: 3618658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term development of intelligence (IQ) and EEG in 34 children with phenylketonuria treated early.
    Pietz J; Benninger C; Schmidt H; Scheffner D; Bickel H
    Eur J Pediatr; 1988 May; 147(4):361-7. PubMed ID: 3396592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of dietary control in phenylketonuric patients and its relationship with general intelligence.
    Vilaseca MA; Lambruschini N; Gómez-López L; Gutiérrez A; Fusté E; Gassió R; Artuch R; Campistol J
    Nutr Hosp; 2010; 25(1):60-6. PubMed ID: 20204257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intellectual development of patients with phenylketonuria; 15-year national screening in The Netherlands].
    Huisman J; van der Schot LW; Hendrikx MM; Kalverboer AF; Slijper FM
    Ned Tijdschr Geneeskd; 1992 Nov; 136(46):2277-81. PubMed ID: 1461293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis.
    Waisbren SE; Noel K; Fahrbach K; Cella C; Frame D; Dorenbaum A; Levy H
    Mol Genet Metab; 2007; 92(1-2):63-70. PubMed ID: 17591452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamics of hyperphenylalaninemia and intellectual outcome in teenagers with phenylketonuria.
    Didycz B; Bik-Multanowski M
    Acta Biochim Pol; 2017; 64(3):527-531. PubMed ID: 28850634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of dietary non-compliance on development in phenylketonuria--studies of 14-year-old patients].
    Theile H; Graustein I; Wässer S; Bührdel P
    Padiatr Padol; 1990; 25(1):19-23. PubMed ID: 2326088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of treatment in young adults with phenylketonuria detected by routine neonatal screening between 1964 and 1971.
    Beasley MG; Costello PM; Smith I
    Q J Med; 1994 Mar; 87(3):155-60. PubMed ID: 8208903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of early detected and early treated phenylketonuria patients.
    Rylance G
    Postgrad Med J; 1989; 65 Suppl 2():S7-9. PubMed ID: 2622815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow up of patients with classical phenylketonuria after diet relaxation at 5 years of age. The Paris Study.
    Rey F; Abadie V; Plainguet F; Rey J
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S39-44. PubMed ID: 8828607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Executive function and psychosocial adjustment in children with early treated phenylketonuria: correlation with historical and concurrent phenylalanine levels.
    Griffiths P; Tarrini M; Robinson P
    J Intellect Disabil Res; 1997 Aug; 41 ( Pt 4)():317-23. PubMed ID: 9297609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.